Patents by Inventor Michael ANDESNER

Michael ANDESNER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FLOCCULANT FUNCTIONALIZED SEPARATION MEDIA
    Publication number: 20250312781
    Abstract: Provided herein are compositions, methods and uses that relate to or result from providing separation media having at least one flocculant ligand covalently attached to a base surface or support, and the separation and/or purification of biological molecules using the separation media of the present disclosure. Certain embodiments provide separation media which under certain modes of operation and enhance the separation of the molecule of interest from impurities. Embodiments are described, for example, for the separation of plasma protein(s) from impurities from plasma-derived samples using separation media disclosed herein.
    Type: Application
    Filed: June 4, 2025
    Publication date: October 9, 2025
    Inventors: Andrew TOMLINSON, Matthew BUCHANAN, Kelly FLOOK, Kevin GALIPEAU, Michael ANDESNER
  • FX ACTIVATION PROCESS AND ITS USE IN THE PREPARATION OF A FXA COMPOSITION
    Publication number: 20250222079
    Abstract: The invention relates to a high purity Coagulation Factor Xa (FXa or activated Coagulation Factor X) preparation and an activation and purification process to obtain said FXa of high purity and high degree of activation without addition of proteinaceous activators during manufacturing.
    Type: Application
    Filed: March 25, 2025
    Publication date: July 10, 2025
    Applicant: OCTAPHARMA AG
    Inventors: Juergen Roland ROEMISCH, Katharina POCK, Petra SCHULZ, Silvio WUSCHKO, Michael ANDESNER, Andrej MURANYI
  • FX activation process and its use in the preparation of a FXa composition
    Patent number: 12274738
    Abstract: The invention relates to a high purity Coagulation Factor Xa (FXa or activated Coagulation Factor X) preparation and an activation and purification process to obtain said FXa of high purity and high degree of activation without addition of proteinaceous activators during manufacturing.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: April 15, 2025
    Assignee: OCTAPHARMA AG
    Inventors: Juergen Roland Roemisch, Katharina Pock, Petra Schulz, Silvio Wuschko, Michael Andesner, Andrej Muranyi
  • FX ACTIVATION PROCESS AND ITS USE IN THE PREPARATION OF A FXA COMPOSITION
    Publication number: 20210290738
    Abstract: The invention relates to a high purity Coagulation Factor Xa (FXa or activated Coagulation Factor X) preparation and an activation and purification process to obtain said FXa of high purity and high degree of activation without addition of proteinaceous activators during manufacturing.
    Type: Application
    Filed: July 8, 2019
    Publication date: September 23, 2021
    Applicant: OCTAPHARMA AG
    Inventors: Juergen Roland ROEMISCH, Katharina POCK, Petra SCHULZ, Silvio WUSCHKO, Michael ANDESNER, Andrej MURANYI